Andrea T. Flynn, MD Andrea T. Flynn, MD, is an attending physician in the Cancer Center at Children's Hospital of Philadelphia. Locations: Main Campus Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467) Education and Training Medical SchoolMD - University of Michigan, Ann Arbor, MI ResidencyPediatrics - Children's Hospital of Philadelphia, Philadelphia, PA FellowshipPediatric Hematology/Oncology - Children's Hospital of Philadelphia, Philadelphia, PA Board CertificationPediatricsGraduate DegreeMS in Pharmacology - Thomas Jefferson University, Philadelphia, PA Titles and Academic Titles Attending PhysicianInstructor, Perelman School of Medicine at the University of Pennsylvania Departments and Services Cancer Center Publications Papers2017 Orenstein L., Coughlin C., Flynn A., Pillai V., Boo M., Wertheim G., Treat J., Teachey D. Severe Mucha-Habermann-like Ulceronecrotic Skin Disease in T-cell ALL Responsive to Basiliximab and Stem Cell Transplant. Pediatric Dermatology, 2017 Sep;34(5):e265-e270. Flynn A., Fox E. Evolving paradigms for new agent development in pediatric oncology. Current Opinions in Pediatrics, Nov 2017 [Epub ahead of print] Posters and Presentations2016 Flynn A, Hogarty M. ODC1 Amplification and Polyamine Depletion in Neuroblastoma: Forming a Responder Hypothesis. Fifth Annual Meeting of NICHD and NICHD-NIGMS T32 Trainees in Pediatric Clinical Pharmacology, September 2016. Flynn A, Benavides A, Vu A, Liu K, Scadden E, Attiyeh E, Haber M, Norris M, Bassiri H, Hogarty M. Effects on tumor cells and the immune microenvironment may both contribute to the anti-tumor activities of DFMO in neuroblastoma in pre-clinical models. Advances in Neuroblastoma Research Congress, June 2016. Flynn AT. Participation of Pediatric Patients in Oncology Research. Presented at: Ethics Conference, Department of Pharmacology Seminars in Human investigation, Thomas Jefferson University; 2016 Sep; Philadelphia, PA. Flynn AT. Polyamine Depletion in Neuroblastoma: Forming a Testable Responder Hypothesis. Presented at: Annual Pediatric Clinical Pharmacology T32 meeting; 2016 Sep; Bethesda, MD. Flynn AT. ODC1 Amplification and Polyamine Dependence in Neuroblastoma: Forming a Responder Hypothesis. Presented at: Post-Doctoral Seminar, Poster Day Winners Symposium, The Children’s Hospital of Philadelphia; 2016 May; Philadelphia, PA. Awards and Honors 2016, Basic Science Award, CHOP Research Poster Day 2015, Clinical Pharmacology T32 Awardee, Children’s Hospital of Philadelphia 2011, Distinction in Service Award, University of Michigan Medical School 2007, Henry Kumpf Memorial Award, Rensselaer Polytechnic Institute, Department of Athletics 2007, Academic All-American At Large, NCAA Field Hockey/Lacrosse, ESPN The Magazine Editorial and Academic Positions Academic and Institutional Committees 2011-present, Graduate Medical Education Committee, Resident/Fellow Representative Leadership and Memberships 2016-present, American College of Clinical Pharmacology (Member) 2015-present, Advances in Neuroblastoma Research Association (Member) 2015-present, American Association for Cancer Research (Member) 2015-present, American Society of Pediatric Hematology/Oncology (Member) 2014-present, Children’s Oncology Group (Member) Patient Experience Ratings About the Patient Experience Rating System The Patient Experience Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question. Responses are measured on a scale of 1 to 5 with 5 being the best score. The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.